TorPharm

TorPharm was a prominent Canadian pharmaceutical company specializing in the development and manufacturing of generic drugs, primarily serving the United States market. As a key subsidiary of Apotex, Canada's largest generic drug producer, TorPharm operated state-of-the-art research and manufacturing facilities in Etobicoke, Ontario. The company gained significant industry recognition for its aggressive legal strategies in challenging pharmaceutical patents, which facilitated the early market introduction of generic versions of blockbuster drugs like paroxetine. In 2004, Apotex consolidated its operations, leading to the full integration of TorPharm into the parent company's corporate structure. The facilities established by TorPharm remain a core component of Apotex's global manufacturing and supply chain infrastructure.